Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

218
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
218
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.8K
Radiological Investigation II: MRI and Ventilation Perfusion Scan01:30

Radiological Investigation II: MRI and Ventilation Perfusion Scan

117
Description
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
117
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Pneumothorax-II01:27

Pneumothorax-II

141
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
141

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Biomarker profiles in idiopathic and progressive pulmonary fibrosis after LPA<sub>1</sub> antagonism: exploratory analysis from a phase 2 trial of admilparant.

Respiratory research·2026
Same author

Acute exacerbation in fibrotic interstitial lung disease: An International Working Group Report.

American journal of respiratory and critical care medicine·2026
Same author

Genome-wide association study of idiopathic pulmonary fibrosis susceptibility using clinically curated European ancestry datasets.

The European respiratory journal·2026
Same author

Deupirfenidone Compared with Pirfenidone and Placebo in Idiopathic Pulmonary Fibrosis (ELEVATE-IPF): a Phase 2b Randomized Placebo-Controlled Trial.

American journal of respiratory and critical care medicine·2026
Same author

Idiopathic pulmonary fibrosis risk loci in East Asian populations mirror those of European populations.

American journal of respiratory and critical care medicine·2026
Same author

A statistical model for lung function trajectory and mortality in patients with fibrotic interstitial lung disease.

American journal of respiratory and critical care medicine·2026

関連する実験動画

Updated: Jun 28, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.9K

インタースティシャル 肺 疾患: 概要

Toby M Maher1,2

  • 1University of Southern California, Los Angeles.

JAMA
|April 22, 2024
PubMed
まとめ

インタースティシャル肺疾患 (ILD) は 65万人のアメリカ人に感染し,呼吸不全と呼吸不全を引き起こします. 抗線維薬,免疫調節薬,肺移植などの治療は,ILD患者の生存率と生活の質を向上させます.

科学分野:

  • 肺科
  • 内科 医学
  • 医学 研究

背景:

  • インタースティシャル肺疾患 (ILD) は,炎症と線維症を引き起こし,漸進的な呼吸不全と呼吸不全を引き起こす肺疾患のグループです.
  • ILDは米国で約65万人に感染し,年間25,000〜30,000人が死亡しています.
  • 常見のILDタイプには,イディオパシー肺線維症 (IPF),過敏性肺炎,結合組織疾患に関連するILDが含まれます.

研究 の 目的:

  • インタースティシャル肺疾患 (ILD) の現在の理解と治療方法を要約します.
  • ILDが患者の健康と生存に与える影響を強調する.
  • 様々な ILD 亜型に対する診断方法と治療介入の見直し.

主な方法:

  • ILDの流行病学,診断,治療に関する既存の文献のレビュー.
  • ILDサブタイプにおける胸部コンピュータトモグラフィの診断精度の分析.
  • 強制生命能力 (FVC) 低下などの予後指標の評価
  • 抗線維薬,免疫調節薬,運動,酸素療法の治療結果の評価
  • 肺移植の結果と末期性肺高血圧の管理に関するレビュー

主要な成果:

さらに関連する動画

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

868
A Standardized Method for Measuring Internal Lung Surface Area via Mouse Pneumonectomy and Prosthesis Implantation
08:46

A Standardized Method for Measuring Internal Lung Surface Area via Mouse Pneumonectomy and Prosthesis Implantation

Published on: July 26, 2017

13.2K

関連する実験動画

Last Updated: Jun 28, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.9K
Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

868
A Standardized Method for Measuring Internal Lung Surface Area via Mouse Pneumonectomy and Prosthesis Implantation
08:46

A Standardized Method for Measuring Internal Lung Surface Area via Mouse Pneumonectomy and Prosthesis Implantation

Published on: July 26, 2017

13.2K
  • ILDは,運動時に呼吸不全があり,患者の30%で咳が報告されています.
  • 胸部CTは,IPFのようなILDサブタイプを診断するための高い感度 (91%) と特異性 (71%) を示しています.
  • FVCが12ヶ月で5%減少すると 死亡リスクが2倍になります
  • 抗線維治療 (ニンテタニブ,ピルフェニドン) は,IPFおよび進行性線維性ILDにおけるFVCの減少を44~57%遅らせます.
  • 免疫調節療法では,CTDに関連したILDにおけるFVCを安定化または改善することができます.
  • 構造的な運動と酸素療法は 症状と生活の質を改善します
  • 肺移植は末期ILDでは移植なし (<2年) と比較して生存率が向上します.
  • 呼吸用トレプロスティニルは,肺高血圧の ILD 患者の症状を改善します.

    • 結論:

    • ILDは,進行性呼吸不全と呼吸不全を緩和するために,早期の診断と管理を必要とします.
    • 第一線治療には,IPFに対するニンテダニブ/ピルフェニドン,CTD-ILDに対するミコフェノラートモフェチルが含まれます.
    • 肺移植は 進行した肺炎の患者にとって 重要な選択肢です
    • 運動訓練は ILD の患者の機能能力と生活の質を高めます